STOCK TITAN

Vita Coco (COCO) director receives 1,530 deferred stock units in grant

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Dozie Aishetu Fatima reported acquisition or exercise transactions in this Form 4 filing.

Vita Coco Company, Inc. director Dozie Aishetu Fatima reported receiving an award of 1,530 shares of common stock on 2026-06-03 as a compensation grant. The filing prices the grant at $75.18 per share. Following this award, she directly holds 16,376 shares of Vita Coco common stock.

According to the footnote, the grant represents deferred restricted stock units under the company’s 2021 Incentive Award Plan. These units vest in full on the earlier of the day immediately before the next Annual Stockholders Meeting after the grant date or the first anniversary of the grant date, provided she continues serving on the board. The deferred RSUs will settle in shares when she ceases service on the board, with each unit delivering one share of Vita Coco common stock.

Positive

  • None.

Negative

  • None.
Insider Dozie Aishetu Fatima
Role null
Type Security Shares Price Value
Grant/Award Common Stock 1,530 $75.18 $115K
Holdings After Transaction: Common Stock — 16,376 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Equity award size 1,530 shares Deferred RSU grant on 2026-06-03
Grant price per share $75.18 per share Valuation of common stock award
Post-grant holdings 16,376 shares Total common shares held directly after transaction
Plan year 2021 Incentive Award Plan Equity plan under which deferred RSUs were granted
deferred RSUs financial
"Represents deferred RSUs granted under the company's 2021 Incentive Award Plan which vest in full..."
2021 Incentive Award Plan financial
"Represents deferred RSUs granted under the company's 2021 Incentive Award Plan which vest in full..."
vest in full financial
"which vest in full the earlier of (i) the day immediately preceding the Annual Stockholders Meeting..."
Annual Stockholders Meeting financial
"the earlier of (i) the day immediately preceding the Annual Stockholders Meeting after the grant date..."
settle financial
"The Reporting Persons deferred RSUs will settle on the date the Reporting Person ceases service on the Board."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Dozie Aishetu Fatima

(Last)(First)(Middle)
111 5TH AVENUE
2ND FLOOR

(Street)
NEW YORK NEW YORK 10003

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/03/2026A1,530(1)A$75.1816,376D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents deferred RSUs granted under the company's 2021 Incentive Award Plan which vest in full the earlier of (i) the day immediately preceding the Annual Stockholders Meeting after the grant date or (ii) the first anniversary of the grant date provided that the Reporting Person remains in continuous service on the applicable vesting date. The Reporting Persons deferred RSUs will settle on the date the Reporting Person ceases service on the Board. Each deferred RSU represents the right to receive one share of common stock of the Issuer.
/s/ Alison Klein, Attorney-in-Fact for Aishetu Fatima Dozie06/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Vita Coco (COCO) report for Dozie Aishetu Fatima?

Vita Coco reported director Dozie Aishetu Fatima received an award of 1,530 shares of common stock valued at $75.18 per share. This was a compensation-related grant, not an open-market stock purchase or sale.

How many Vita Coco (COCO) shares does Dozie Aishetu Fatima hold after this grant?

After the reported grant, director Dozie Aishetu Fatima holds 16,376 Vita Coco common shares directly. This total includes the new 1,530-share compensation award reported in the Form 4 insider filing.

What type of equity award did Vita Coco (COCO) grant to its director?

The company granted deferred restricted stock units (RSUs) under its 2021 Incentive Award Plan. Each deferred RSU entitles the director to receive one Vita Coco common share when the units settle after board service ends, subject to vesting conditions.

When do the deferred RSUs granted by Vita Coco (COCO) vest for the director?

The deferred RSUs vest in full on the earlier of the day immediately before the next Annual Stockholders Meeting after the grant date or the first anniversary of the grant date, if the director continues serving on the board during that period.

When will Vita Coco (COCO) settle the director’s deferred RSUs into shares?

Vita Coco will settle the director’s deferred RSUs on the date she ceases service on the board. At settlement, each vested unit converts into one share of the company’s common stock, delivering the underlying equity at that time.